These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 2580397)
41. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Kronborg G APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034 [TBL] [Abstract][Full Text] [Related]
42. Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. Witko-Sarsat V; Allen RC; Paulais M; Nguyen AT; Bessou G; Lenoir G; Descamps-Latscha B J Immunol; 1996 Sep; 157(6):2728-35. PubMed ID: 8805680 [TBL] [Abstract][Full Text] [Related]
43. Cystic fibrosis ciliary dyskinesia substances and pulmonary disease. Effects of ciliary dyskinesia substances on neutrophil movement in vitro. Wilson GB; Fudenberg HH; Parise MT; Floyd E J Clin Invest; 1981 Jul; 68(1):171-83. PubMed ID: 7251858 [TBL] [Abstract][Full Text] [Related]
44. Controlled comparison of plasma and serum for cystic fibrosis protein. Wilson GB; McIntosh J; Dietrich J; Manning T Clin Genet; 1984 Oct; 26(4):331-8. PubMed ID: 6499249 [TBL] [Abstract][Full Text] [Related]
45. Increased heparin binding in cystic fibrosis: a reflection of altered glycoprotein biosynthesis? Pearson RD; Lubin AH Pediatr Res; 1979 Jul; 13(7):834-40. PubMed ID: 481956 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and secretion of cystic fibrosis ciliary dyskinesia substances by purified subpopulations of leukocytes. Wilson GB; Bahm VJ J Clin Invest; 1980 Nov; 66(5):1010-9. PubMed ID: 7430342 [TBL] [Abstract][Full Text] [Related]
47. Tissue localization and chromosomal assignment of a serum protein that tracks the cystic fibrosis gene. van Heyningen V; Hayward C; Fletcher J; McAuley C Nature; 1985 Jun 6-12; 315(6019):513-5. PubMed ID: 2582274 [TBL] [Abstract][Full Text] [Related]
48. Ciliary dyskinesia factors in cystic fibrosis and asthma. Wilson CB; Fudenberg HH Nature; 1977 Mar; 266(5601):463-4. PubMed ID: 67566 [No Abstract] [Full Text] [Related]
49. Cystic fibrosis protein, a confirmed diagnostic marker for detecting heterozygote carriers: significance in relation to future screening and to a proposed primary defect in alpha 2-macroglobulin. Wilson GB Pediatr Res; 1979 Sep; 13(9):1079-81. PubMed ID: 92006 [No Abstract] [Full Text] [Related]
50. A purified serum glycopeptide from controls and cystic fibrosis patients. I. Comparison of their mucociliary activity on rabbit tracheal explants. Blitzer MG; Shapira E Pediatr Res; 1982 Mar; 16(3):203-8. PubMed ID: 7063275 [TBL] [Abstract][Full Text] [Related]
51. Serum concentrations of a granulocyte-derived calcium-binding protein in cystic fibrosis patients and heterozygotes. Hayward C; Glass S; van Heyningen V; Brock DJ Clin Chim Acta; 1987 Nov; 170(1):45-55. PubMed ID: 3436044 [TBL] [Abstract][Full Text] [Related]
52. Assessment of the tracheal ring bioassay for detection of the cystic fibrosis serum factor. Ma DI; Fondacaro JD Life Sci; 1983 Jun; 32(25):2849-53. PubMed ID: 6855474 [TBL] [Abstract][Full Text] [Related]
53. Serum complement (C'3a and C'5)-induced inhibition of rabbit tracheal cilia. Kennedy JR; Lin KT; Duckett KE Prog Clin Biol Res; 1982; 80():71-5. PubMed ID: 6980422 [No Abstract] [Full Text] [Related]